191 related articles for article (PubMed ID: 10083018)
1. The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels.
Meiser BM; Pfeiffer M; Schmidt D; Ueberfuhr P; Reichenspurner H; Paulus D; von Scheidt W; Kreuzer E; Seidel D; Reichart B
Transplant Proc; 1999; 31(1-2):84-7. PubMed ID: 10083018
[No Abstract] [Full Text] [Related]
2. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
[No Abstract] [Full Text] [Related]
3. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
[TBL] [Abstract][Full Text] [Related]
4. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression.
Narayanan M; Pankewycz O; El-Ghoroury M; Shihab F; Wiland A; McCague K; Chan L
Transplantation; 2013 Feb; 95(4):566-72. PubMed ID: 23423268
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring.
Meiser BM; Pfeiffer M; Schmidt D; Reichenspurner H; Ueberfuhr P; Paulus D; von Scheidt W; Kreuzer E; Seidel D; Reichart B
J Heart Lung Transplant; 1999 Feb; 18(2):143-9. PubMed ID: 10194038
[TBL] [Abstract][Full Text] [Related]
7. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience.
Rhu J; Lee KW; Park H; Park JB; Kim SJ; Choi GS
Ann Transplant; 2017 Nov; 22():707-718. PubMed ID: 29180612
[TBL] [Abstract][Full Text] [Related]
9. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
Hesse CJ; Vantrimpont P; van Riemsdijk-van Overbeeke IC; van Gelder T; Balk AH; Weimar W
Transplant Proc; 2001 May; 33(3):2163-4. PubMed ID: 11377487
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil: pharmacokinetic strategies for optimizing immunosuppression.
Shaw LM
Drug Metabol Drug Interact; 1997; 14(1):33-40. PubMed ID: 9713576
[No Abstract] [Full Text] [Related]
11. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
[No Abstract] [Full Text] [Related]
12. Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.
Mehra MR; Uber PA; Scott RL; Prasad AK; Park MH
Transplant Proc; 2001; 33(1-2):1613-4. PubMed ID: 11267442
[No Abstract] [Full Text] [Related]
13. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
14. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
Hunt SA
Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
[No Abstract] [Full Text] [Related]
16. Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
Taylor DO; Barr ML; Meiser BM; Pham SM; Mentzer RM; Gass AL
J Heart Lung Transplant; 2001 Jul; 20(7):734-8. PubMed ID: 11448799
[No Abstract] [Full Text] [Related]
17. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
[No Abstract] [Full Text] [Related]
18. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G
Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience.
El-Sabrout R; Delaney V; Qadir M; Butt F; Hanson P; Butt KM
Transplant Proc; 2003 May; 35(3 Suppl):89S-94S. PubMed ID: 12742474
[No Abstract] [Full Text] [Related]
20. Low systemic exposure to tacrolimus correlates with acute rejection.
Undre NA; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales JM; Andrés A; Schäfer A; Stevenson P
Transplant Proc; 1999; 31(1-2):296-8. PubMed ID: 10083114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
